Book chapter · 2017

Neuroinflammation as a therapeutic target in neurodegenerative diseases

Richard Gordon, Trent M. Woodruff

Elsevier eBooks, 49–80 · Published 1 January 2017 · DOI 10.1016/b978-0-12-805120-7.00003-8

View at the publisherCite this paper

In brief

“Neuroinflammation as a therapeutic target in neurodegenerative diseases” is a 2017 book chapter by Richard Gordon and Trent M. Woodruff, published in Elsevier eBooks. OpenAlex counts 19 citations as of 15 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
19
Most cited in
2025 (4)
Field-weighted impact
1.91
References
231
Authors
2

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Gordon, R., & Woodruff, T. M. (2017). Neuroinflammation as a therapeutic target in neurodegenerative diseases. Elsevier eBooks, 49–80. https://doi.org/10.1016/b978-0-12-805120-7.00003-8

MLA 9

Gordon, Richard, and Trent M. Woodruff. “Neuroinflammation as a therapeutic target in neurodegenerative diseases.” Elsevier eBooks, 2017, pp. 49–80. https://doi.org/10.1016/b978-0-12-805120-7.00003-8.

Chicago

Gordon, Richard and Trent M. Woodruff. 2017. “Neuroinflammation as a therapeutic target in neurodegenerative diseases.” Elsevier eBooks: 49–80. https://doi.org/10.1016/b978-0-12-805120-7.00003-8.

Harvard

Gordon, R. and Woodruff, T. M. (2017) ‘Neuroinflammation as a therapeutic target in neurodegenerative diseases’, Elsevier eBooks, pp. 49–80. doi:10.1016/b978-0-12-805120-7.00003-8.

IEEE

R. Gordon and T. M. Woodruff, “Neuroinflammation as a therapeutic target in neurodegenerative diseases,” Elsevier eBooks, pp. 49–80, 2017, doi: 10.1016/b978-0-12-805120-7.00003-8.

BibTeX

@incollection{gordon2017neuroinflammation,
  title     = {{Neuroinflammation as a therapeutic target in neurodegenerative diseases}},
  author    = {Gordon, Richard and Woodruff, Trent M.},
  booktitle = {Elsevier eBooks},
  publisher = {Elsevier BV},
  year      = {2017},
  pages     = {49--80},
  doi       = {10.1016/b978-0-12-805120-7.00003-8},
  url       = {https://doi.org/10.1016/b978-0-12-805120-7.00003-8}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201911
202011
202122
202233
202311
202433
202544
202644

Its field-weighted citation impact is 1.91: it has been cited 1.91 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms

  • neuroinflammation
  • neurodegenerative diseases
  • chronic neuroinflammation
  • disease progression
  • therapeutic target
  • anti-inflammatory agents
  • drug development
  • preclinical models

Work with this paper

Most-cited papers in Neuroscience

All highly cited Neuroscience papers

Questions about this paper

How do I cite this paper in APA style?

Gordon, R., & Woodruff, T. M. (2017). Neuroinflammation as a therapeutic target in neurodegenerative diseases. Elsevier eBooks, 49–80. https://doi.org/10.1016/b978-0-12-805120-7.00003-8

How many times has this paper been cited?

19 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Richard Gordon, Trent M. Woodruff.

What is the DOI of this paper?

10.1016/b978-0-12-805120-7.00003-8. The permanent link is https://doi.org/10.1016/b978-0-12-805120-7.00003-8.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.